174417-17-5 Usage
Molecular structure
2,2,2-TRICHLORO-1-[4-(4-METHOXYBENZOYL)-1H-PYRROL-2-YL]-1-ETHANONE consists of a complex structure with trichloroethanone, a pyrrole ring, and a methoxybenzoyl group.
Trichloroethanone derivative
The compound is derived from acetone, with all three hydrogen atoms replaced by chlorine atoms, resulting in a more reactive and versatile structure.
Heterocyclic aromatic compound
The presence of a pyrrole ring, which is a five-membered heterocyclic aromatic organic compound, contributes to the compound's unique chemical properties.
Methoxybenzoyl group
The addition of a methoxybenzoyl group further increases the complexity of the chemical and may influence its reactivity and potential applications.
Synthetic chemical
2,2,2-TRICHLORO-1-[4-(4-METHOXYBENZOYL)-1H-PYRROL-2-YL]-1-ETHANONE is a synthetic chemical, meaning it is created through human-made processes rather than occurring naturally.
Potential applications
This chemical has potential applications in various industries, including pharmaceuticals and agrochemicals, due to its unique structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 174417-17-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,4,1 and 7 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 174417-17:
(8*1)+(7*7)+(6*4)+(5*4)+(4*1)+(3*7)+(2*1)+(1*7)=135
135 % 10 = 5
So 174417-17-5 is a valid CAS Registry Number.
174417-17-5Relevant articles and documents
The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38α MAP kinase
Down, Kenneth,Bamborough, Paul,Alder, Catherine,Campbell, Amanda,Christopher, John A.,Gerelle, Maria,Ludbrook, Steve,Mallett, Dave,Mellor, Geoff,Miller, David D.,Pearson, Rosannah,Ray, Keith,Solanke, Yemisi,Somers, Don
scheme or table, p. 3936 - 3940 (2010/08/19)
A novel pyrrole-2-carboxamide series of p38α inhibitors, discovered through the application of virtual screening, is presented. Following evaluation of activity, selectivity and developability properties of commercially available analogues, a synthesis program enabled rapid assessment of the series' suitability for further lead optimisation studies.
